OSSIO vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
OSSIO is an orthopedic medical device company offering biocomposite fixation implants that resorb and are replaced by natural bone; OSSIOfiber technology avoids metal implant removal surgeries; raised $72M+ in total funding;
About
OSSIO is a medical device company founded in 2015 and headquartered in Andover, Massachusetts, that develops biocomposite orthopedic fixation implants as an alternative to traditional metal hardware. The company's proprietary OSSIOfiber technology platform combines a bioabsorbable polymer matrix reinforced with mineral fibers to create implants that are strong enough to stabilize bone during healing, yet gradually resorb and are replaced by the patient's own natural bone tissue over time. This eliminates the need for a second surgery to remove metal hardware — a common procedure with titanium screws and plates — reducing total patient burden and healthcare costs. OSSIOfiber implants are FDA-cleared for use in the foot, ankle, and hand.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.